Depression in cancer

Managing 'fear of recurrence' of cancer patients

Psychological issues in familial cancer

Durable responses in aRCC, how do we optimise treatment?

Bladder cancer updates from the first half of 2024

Patient expectations and shared decision making in aRCC

Best practice in HRRm testing in patients with metastatic prostate cancer

Enfortumab vedotin improves efficacy outcomes in locally advanced or metastatic urothelial cancer across all exposure quartiles

ARV-766 well tolerated and shows promising clinical activity in metastatic castration-resistant prostate cancer

Neoadjuvant sacituzumab govitecan shows promising activity in muscle-invasive urothelial bladder cancer

Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC

Addition of cabazitaxel to abiraterone/prednisone significantly prolonged PFS in extensive mCRPC following docetaxel